News Daily News More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials Michael O'Riordan October 28, 2022
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Conference News ESC 2019 Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories Yael L. Maxwell September 06, 2019
News Conference News ESC 2019 New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD Shelley Wood August 31, 2019
News Conference News ESC 2018 Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND Michael O'Riordan August 26, 2018